Advisor Group’s VolitionRx Ltd VNRX Stock Holding History

Advisor Group’s Portfolio VNRX Stock Details VNRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$94K	Buy	989 +250	+34%	+$25.9K	﹤0.01%	2987
2019 Q3	$83K	Buy	739 +250	+51%	+$19.9K	﹤0.01%	3035
2019 Q2	$31K	Hold	489	–	–	﹤0.01%	3681
2019 Q1	$32K	Hold	489	–	–	﹤0.01%	3696
2018 Q4	$18K	Hold	489	–	–	﹤0.01%	3888
2018 Q3	$25K	Hold	489	–	–	﹤0.01%	3757
2018 Q2	$20K	Hold	489	–	–	﹤0.01%	3720
2018 Q1	$23K	Hold	489	–	–	﹤0.01%	3606
2017 Q4	$29K	Sell	489 -86	-15%	-$5.03K	﹤0.01%	3468
2017 Q3	$30K	Buy	575 +200	+53%	+$11.7K	﹤0.01%	3318
2017 Q2	$27K	Hold	375	–	–	﹤0.01%	3297
2017 Q1	$30K	Hold	375	–	–	﹤0.01%	3088
2016 Q4	$34K	Hold	375	–	–	﹤0.01%	2884
2016 Q3	$40K	Buy	+375	New	+$29.1K	﹤0.01%	2704

Other funds holding VNRX

LIM

Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Aristides Capital Louisville, Kentucky $462M AUM 28.94% 1-Year Est. Return

Advisor Group's VNRX Position: Q4 2019 in Review

Advisor Group increased its VolitionRx Ltd (VNRX) stake by 34% in Q4 2019, buying an estimated $25.9K and bringing the position to 989 shares worth $94K. The position accounts for ﹤0.01% of the portfolio, ranked #2987.

Advisor Group first reported a position in VNRX in Q3 2016 and has held it in 14 quarters since. 36 funds tracked by Wall St. Rank hold VNRX as of Q4 2019.

Advisor Group held 989 shares of VolitionRx Ltd worth $94K as of Q4 2019.
Advisor Group bought 250 VolitionRx Ltd shares in Q4 2019, an estimated $25.9K.
VolitionRx Ltd made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #2987 holding.
Advisor Group first reported a position in VolitionRx Ltd in Q3 2016 and has held it in 14 quarters since.
36 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.